S8:E3 – Oncology Morning Commute: ADCs for NSCLC—Ready for Prime Time?

Hematology / Oncology @Point of Care Podcasts

English - March 28, 2022 16:30 - 18 minutes - 25.4 MB
Medicine Health & Fitness checkpointinhibitors cmece endometrialcancer immunotherapy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: S8:E2 – Oncology Morning Commute: PD-L1 Expression in NSCLC

Next Episode: S9:E1 – Oncology Journal Club: Covid-19 and CLL Implications for Treatment Decision-Making

Our faculty discuss exciting developments in targeted therapies for non-small cell lung cancer, specifically the promise of antibody-drug conjugates as treatment for this disease. But are they ready for prime time?

Visit http://morningcommutepodcast.com/nsclc6 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit